ACTONEL (Warner Chilcott Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the ACTONEL drug offered from Warner Chilcott Pharmaceuticals Inc.. This Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Warner Chilcott Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | RISEDRONATE SODIUM |
SUBSTANCE NAME: | RISEDRONATE SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1998-03-27 |
END MARKETING DATE: | 0000-00-00 |
ACTONEL HUMAN PRESCRIPTION DRUG Details:
Item Description | ACTONEL from Warner Chilcott Pharmaceuticals Inc. |
LABELER NAME: | Warner Chilcott Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 30(mg/1) |
START MARKETING DATE: | 1998-03-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0149-0470_05985725-417c-44f4-9e38-4fed7cdfdaad |
PRODUCT NDC: | 0149-0470 |
APPLICATION NUMBER: | NDA020835 |
Other RISEDRONATE SODIUM Pharmaceutical Manufacturers / Labelers: